Document Detail


Biosynthesis of pipecolic acid by RapL, a lysine cyclodeaminase encoded in the rapamycin gene cluster.
MedLine Citation:
PMID:  16536560     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Rapamycin, FK506, and FK520 are immunosuppressant macrolactone natural products comprised of predominantly polyketide-based core structures. A single nonproteinogenic pipecolic acid residue is installed into the scaffold by a nonribosomal peptide synthetase that also performs the subsequent macrocyclization step at the carbonyl group of this amino acid. It has been assumed that pipecolic acid is generated from lysine by the cyclodeaminases RapL/FkbL. Herein we report the heterologous overexpression and purification of RapL and validate its ability to convert L-lysine to L-pipecolic acid by a cyclodeamination reaction that involves redox catalysis. RapL also accepts L-ornithine as a substrate, albeit with a significantly reduced catalytic efficiency. Turnover is presumed to encompass a reversible oxidation at the alpha-amine, internal cyclization, and subsequent re-reduction of the cyclic delta1-piperideine-2-carboxylate intermediate. As isolated, RapL has about 0.17 equiv of tightly bound NAD+, suggesting that the enzyme is incompletely loaded when overproduced in E. coli. In the presence of exogenous NAD+, the initial rate is elevated 8-fold with a Km of 2.3 microM for the cofactor, consistent with some release and rebinding of NAD+ during catalytic cycles. Through the use of isotopically labeled substrates, we have confirmed mechanistic details of the cyclodeaminase reaction, including loss of the alpha-amine and retention of the hydrogen atom at the alpha-carbon. In addition to the characterization of a critical enzyme in the biosynthesis of a medically important class of natural products, this work represents the first in vitro characterization of a lysine cyclodeaminase, a member of a unique group of enzymes which utilize the nicotinamide cofactor in a catalytic manner.
Authors:
Gregory J Gatto; Michael T Boyne; Neil L Kelleher; Christopher T Walsh
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural    
Journal Detail:
Title:  Journal of the American Chemical Society     Volume:  128     ISSN:  0002-7863     ISO Abbreviation:  J. Am. Chem. Soc.     Publication Date:  2006 Mar 
Date Detail:
Created Date:  2006-03-15     Completed Date:  2006-05-25     Revised Date:  2007-11-14    
Medline Journal Info:
Nlm Unique ID:  7503056     Medline TA:  J Am Chem Soc     Country:  United States    
Other Details:
Languages:  eng     Pagination:  3838-47     Citation Subset:  IM    
Affiliation:
Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts 02115, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Amino Acid Sequence
Ammonia-Lyases / antagonists & inhibitors,  genetics,  isolation & purification,  metabolism*
Enzyme Inhibitors / pharmacology
Escherichia coli / genetics,  metabolism
Kinetics
Molecular Sequence Data
Nipecotic Acids / pharmacology
Pipecolic Acids / metabolism*
Recombinant Proteins / genetics,  metabolism
Sirolimus / metabolism
Grant Support
ID/Acronym/Agency:
F32GM069169/GM/NIGMS NIH HHS; GM020011/GM/NIGMS NIH HHS; GM067725/GM/NIGMS NIH HHS; T32GM07283/GM/NIGMS NIH HHS
Chemical
Reg. No./Substance:
0/Enzyme Inhibitors; 0/Nipecotic Acids; 0/Pipecolic Acids; 0/Recombinant Proteins; 53123-88-9/Sirolimus; 535-75-1/pipecolic acid; EC 4.3.1.-/Ammonia-Lyases; EC 4.3.1.-/lysine cyclodeaminase

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  A two-photon antenna for photochemical delivery of nitric oxide from a water-soluble, dye-derivatize...
Next Document:  Characterization by LC-MS(n) of four new classes of chlorogenic acids in green coffee beans: dimetho...